This inventor holds 5 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Mirvie, Inc., Grail, Inc., The Chinese University of Hong Kong. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2026
Title: Eugeni Namsaraev: Innovator in Cancer Detection Technologies
Introduction: Eugeni Namsaraev is an accomplished inventor based in Palo Alto, CA. He is currently associated with Grail, Inc., where he focuses on developing advanced methods for cancer detection. Despite having no granted patents to his name, his contributions to the field of medical diagnostics are noteworthy.
Latest Patent Applications: Eugeni Namsaraev has been involved in several innovative patent applications aimed at improving cancer detection. One of his latest applications is titled "Methods and Systems for Tumor Detection." This application provides methods to enhance the positive predictive value for cancer detection using cell-free nucleic acid samples. Various embodiments are directed towards diagnostic applications that analyze fragmentation patterns and sizes of cell-free DNA, including nucleic acids from pathogens. Another significant application is "Methods of Analyzing Nucleic Acid Fragments," which outlines methods for enriching biological samples for target nucleic acids associated with cancer or tumors. These applications demonstrate his commitment to advancing cancer diagnostics and improving patient outcomes.
Conclusion: Eugeni Namsaraev is a dedicated inventor whose work in cancer detection technologies holds promise for the future of medical diagnostics. His innovative approaches aim to enhance the accuracy of cancer detection, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile